Cannlabs (OTCMKTS:CANL – Get Free Report) and PACS Group (NYSE:PACS – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, risk, dividends, institutional ownership, analyst recommendations, earnings and valuation.
Earnings and Valuation
This table compares Cannlabs and PACS Group”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cannlabs | N/A | N/A | N/A | N/A | N/A |
| PACS Group | $4.09 billion | 1.47 | $55.76 million | $1.05 | 36.61 |
Risk and Volatility
Cannlabs has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500. Comparatively, PACS Group has a beta of -0.68, suggesting that its share price is 168% less volatile than the S&P 500.
Profitability
This table compares Cannlabs and PACS Group’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cannlabs | N/A | N/A | N/A |
| PACS Group | 3.29% | 21.39% | 3.09% |
Analyst Recommendations
This is a breakdown of current ratings and target prices for Cannlabs and PACS Group, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cannlabs | 0 | 0 | 0 | 0 | 0.00 |
| PACS Group | 1 | 1 | 5 | 0 | 2.57 |
PACS Group has a consensus target price of $39.40, indicating a potential upside of 2.50%. Given PACS Group’s stronger consensus rating and higher possible upside, analysts clearly believe PACS Group is more favorable than Cannlabs.
Summary
PACS Group beats Cannlabs on 7 of the 8 factors compared between the two stocks.
About Cannlabs
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
About PACS Group
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.
Receive News & Ratings for Cannlabs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannlabs and related companies with MarketBeat.com's FREE daily email newsletter.
